Scale-up Systems and ScienView Team Up on Process Development
News May 14, 2013
Scale-up Systems Ltd. announced it has entered into a multi-year agreement with ScienView Co. Ltd. to provide DynoChem® software, training and process development support services to the Chinese pharmaceutical industry.
The motivation behind the agreement is to provide a dedicated local presence to help Chinese users to obtain maximum value from DynoChem’s tools. The initial team in the Beijing and Shanghai offices will be led by Dr. Jinjun Wang for Training & Technical Support and Jack Ma on the Business side.
According to Scale-up Systems CEO Dr. Joe Hannon, “We have been looking for a partner in China that, like our company, specialises in working with and understands the needs of the pharma and life sciences industry. We are therefore delighted to be working with ScienView.”
Scale-up Systems COO Dr. Steve Hearn said “What made ScienView stand out to us was the value it placed on hiring high quality training and support staff across multiple domains.”
ScienView’s Vice President of Informatics Services, Dr. Zhen Wang stated, “Many of our clients are pharmaceutical, chemical or CRO companies, and they are delighted to know that DynoChem will be provided to them along with our top-quality support. With the rapidly increasing R&D investments in China, businesses here also face significant challenges on managing costs and reducing pollution. DynoChem is an excellent tool to help them achieve these goals and is complementary to our products and services.”
Jack Ma, Business Development Manager for ScienView, added that “as the founder of the Shanghai Scientific Informatics Salon, a technical networking forum for big pharma, CRO and chemical companies as well as academics, ScienView finds that scientists and engineers here are very interested in new techniques and tools that can be applied successfully to their work and can be effectively supported by a local team.”
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Sysmex Partners with Laboratories to Deliver Improved QC ManagementNews
Sysmex America has announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018